Across TCGA pan-cancer cohorts, LINC02026 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated LINC02026 data layer compared with 21 for mass-spec protein.

The strongest signal is observed in kidney chromophobe (KICH), where higher LINC02026 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC02026 expression acts as an unfavorable survival marker.

KICH, BLCA, and ESCA are the cancer types where LINC02026 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	DFS	Median	All	0.043	0.971	<.001	33	view →
BLCA	OS	Median	All	0.229	0.720	.012	18	view →
ESCA	OS	Median	II,III,IV	0.321	0.685	.035	3	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: LINC02026 tumor-vs-normal RNA expression · all LINC02026 data types